{"id":2157,"date":"2021-11-11T14:18:34","date_gmt":"2021-11-11T14:18:34","guid":{"rendered":"https:\/\/pprd.theramex.com\/pt\/?p=2157"},"modified":"2021-11-11T14:18:34","modified_gmt":"2021-11-11T14:18:34","slug":"theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po","status":"publish","type":"post","link":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/","title":{"rendered":"Theramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio"},"content":{"rendered":"\n

FOR MEDIA AND INVESTORS ONLY<\/strong><\/p>\n\n\n\n

LONDON, UK \u2013 November 2021<\/strong> \u2013 Theramex, a global company specialised in women\u2019s health, announced that it has received Decentralised procedure (DCP) approval for Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe in Portugal, Germany and France. Marketing authorisations for Germany and Portugal are expected by the end of the year, with France having already received its marketing authorization.<\/p>\n\n\n\n

Further DCP or National Applications are being submitted in Europe and other countries worldwide.<\/p>\n\n\n\n

Gavin Jelic-Masterton<\/strong>, Theramex President of the Global Fertility Franchise, said, \u201cThis is a significant day for the Fertility Franchise at Theramex. It clearly demonstrates our commitment to building a first-class portfolio of products giving IVF physicians, and patients, much needed increased choice.\u201d<\/em><\/p>\n\n\n\n

Robert Stewart<\/strong>, CEO at Theramex says, \u201cHelping women to build families is critical to the role of Theramex and I am delighted to add Ganirelix to our growing Fertility Franchise.\u201d<\/em><\/p>\n\n\n\n

Theramex acquired rights to Ganirelix in these markets from GP Pharm, a private Spanish biopharmaceutical firm, committed to bringing science to society<\/p>\n\n\n\n

Dr. Antonio Parente<\/strong>, President Executive of GP Pharm says \u201cWe are very excited about the collaboration with Theramex due to their solid position in the fertility field and we believe that it will be a successful partnership. This collaboration will allow us to continue building on our corporate vision of making injectable products available worldwide\u201d.<\/em><\/p>\n\n\n\n

<\/p>\n","protected":false},"excerpt":{"rendered":"

FOR MEDIA AND INVESTORS ONLY LONDON, UK \u2013 November 2021 \u2013 Theramex, a global company specialised in women\u2019s health, announced that it has received Decentralised procedure (DCP) approval for Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe in Portugal, Germany and France. Marketing authorisations for Germany and Portugal are expected by the […]<\/p>\n","protected":false},"author":31,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2157","post","type-post","status-publish","format-standard","hentry","category-uncategorised"],"acf":[],"yoast_head":"\nTheramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio - Theramex Portugal<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Theramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio - Theramex Portugal\" \/>\n<meta property=\"og:description\" content=\"FOR MEDIA AND INVESTORS ONLY LONDON, UK \u2013 November 2021 \u2013 Theramex, a global company specialised in women\u2019s health, announced that it has received Decentralised procedure (DCP) approval for Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe in Portugal, Germany and France. Marketing authorisations for Germany and Portugal are expected by the […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/\" \/>\n<meta property=\"og:site_name\" content=\"Theramex Portugal\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-11T14:18:34+00:00\" \/>\n<meta name=\"author\" content=\"garethwesley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"garethwesley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\\\/\"},\"author\":{\"name\":\"garethwesley\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#\\\/schema\\\/person\\\/4a1ee296d18078c874f0f4cf868281f3\"},\"headline\":\"Theramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg\\\/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio\",\"datePublished\":\"2021-11-11T14:18:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\\\/\"},\"wordCount\":257,\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\\\/\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\\\/\",\"name\":\"Theramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg\\\/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio - Theramex Portugal\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#website\"},\"datePublished\":\"2021-11-11T14:18:34+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#\\\/schema\\\/person\\\/4a1ee296d18078c874f0f4cf868281f3\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Theramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg\\\/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#website\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/\",\"name\":\"Theramex Portugal\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/#\\\/schema\\\/person\\\/4a1ee296d18078c874f0f4cf868281f3\",\"name\":\"garethwesley\",\"url\":\"https:\\\/\\\/www.theramex.com\\\/pt\\\/novidades\\\/author\\\/garethwesley\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Theramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio - Theramex Portugal","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/","og_locale":"en_GB","og_type":"article","og_title":"Theramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio - Theramex Portugal","og_description":"FOR MEDIA AND INVESTORS ONLY LONDON, UK \u2013 November 2021 \u2013 Theramex, a global company specialised in women\u2019s health, announced that it has received Decentralised procedure (DCP) approval for Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe in Portugal, Germany and France. Marketing authorisations for Germany and Portugal are expected by the […]","og_url":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/","og_site_name":"Theramex Portugal","article_published_time":"2021-11-11T14:18:34+00:00","author":"garethwesley","twitter_card":"summary_large_image","twitter_misc":{"Written by":"garethwesley","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/#article","isPartOf":{"@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/"},"author":{"name":"garethwesley","@id":"https:\/\/www.theramex.com\/pt\/#\/schema\/person\/4a1ee296d18078c874f0f4cf868281f3"},"headline":"Theramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio","datePublished":"2021-11-11T14:18:34+00:00","mainEntityOfPage":{"@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/"},"wordCount":257,"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/","url":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/","name":"Theramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio - Theramex Portugal","isPartOf":{"@id":"https:\/\/www.theramex.com\/pt\/#website"},"datePublished":"2021-11-11T14:18:34+00:00","author":{"@id":"https:\/\/www.theramex.com\/pt\/#\/schema\/person\/4a1ee296d18078c874f0f4cf868281f3"},"breadcrumb":{"@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.theramex.com\/pt\/novidades\/theramex-makes-a-further-step-towards-the-consolidation-of-the-fertility-footprint-by-adding-ganirelix-acetate-0-25-mg-0-5-ml-solution-for-injection-in-pre-filled-syringe-to-the-existing-fertility-po\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.theramex.com\/pt\/"},{"@type":"ListItem","position":2,"name":"Theramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg\/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio"}]},{"@type":"WebSite","@id":"https:\/\/www.theramex.com\/pt\/#website","url":"https:\/\/www.theramex.com\/pt\/","name":"Theramex Portugal","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.theramex.com\/pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/www.theramex.com\/pt\/#\/schema\/person\/4a1ee296d18078c874f0f4cf868281f3","name":"garethwesley","url":"https:\/\/www.theramex.com\/pt\/novidades\/author\/garethwesley\/"}]}},"_links":{"self":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/posts\/2157","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/comments?post=2157"}],"version-history":[{"count":0,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/posts\/2157\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/media?parent=2157"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/categories?post=2157"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.theramex.com\/pt\/wp-json\/wp\/v2\/tags?post=2157"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}